GreenLight Biosciences gains on deal to be acquired by Fall Line Capital
** GreenLight Biosciences Holdings PBC's GRNA.O shares up
40% premarket at $0.28; among top pct gainers across U.S.
exchanges
** Company to be acquired by group of buyers led by Fall
Line Capital LLC in all-cash transaction valuing GRNA at ~$45.5
mln
** Upon completion of transaction, GRNA will become
privately held company
** As of last close, GreenLight shares down ~83% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com))
Recent news on Greenlight Biosciences Holdings PBC
See all newsBrief: Greenlight Biosciences To Cut Workforce By About 51%
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital